Contract facts
UnrestrictedNo full NAICS 811210 intel page yet. Browse NAICS intelligence
COMPLETE SERVICE AGREEMENT FOR TWO (2) OPERETTA CLS HIGH-CONTENT IMAGING SYSTEMS , SIX (6) OPERA PHENIX CONFOCAL MICROSCOPY SYSTEMS, AND ASSOCIATED INTEGRATED EQUIPMENT is a federal Unrestricted award for National Institutes Of Health Olao held by Revvity Health Sciences, Inc. Estimated value $770K ($770K obligated). Current period of performance ends Sep 23, 2027. Last award drew 1 bidder. Place of performance: HOPKINTON MA. Related solicitation NOI-NIAID-26-01542.
COMPLETE SERVICE AGREEMENT FOR TWO (2) OPERETTA CLS HIGH-CONTENT IMAGING SYSTEMS , SIX (6) OPERA PHENIX CONFOCAL MICROSCOPY SYSTEMS, AND ASSOCIATED INTEGRATED EQUIPMENT
Recompete timing
PublicCurrent PoP ends Sep 23, 2027 (361 days remaining). Agencies typically plan 12–18 months ahead — at 11.9 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N98026P00405? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRevvity Health Sciences, Inc — $19.9M obligated across 263 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N98026P00405?
75N98026P00405 (Complete service agreement for TWO (2)) is a National Institutes Of Health Olao award with a potential value of $770K, currently held by Revvity Health Sciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N98026P00405?
National Institutes Of Health Olao awarded 75N98026P00405 to Revvity Health Sciences, Inc (potential $770K).
Who is the incumbent on 75N98026P00405?
Revvity Health Sciences, Inc is the incumbent with $19.9M across 263 related awards in SCOUT’s public footprint. The current period of performance ends Sep 23, 2027.
When does Revvity Health Sciences, Inc’s 75N98026P00405 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 23, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N98026P00405? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.